Terms ending in 2035
Yeda Research and Development Co. Ltd.
Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,066,014 | Anti CD84 Antibodies, Compositions Comprising Same and Uses Thereof In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 10,125,365 | Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 10,611,839 | Anti CD84 Antibodies, Compositions Comprising Same and Uses Thereof In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 10,975,373 | Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 11,680,263 | Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 10,053,712 | Use of Enzymes Which Catalyze Pyruvate Synthesis from Formate and Acetyl-Coa and Bacteria Expressing Same In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 9,815,757 | Preparation of Aldehydes and Ketones from Alkenes Using Polyoxometalate Catalysts and Nitrogen Oxides In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 9,394,365 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 9,512,225 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 9,512,227 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | |
| 37 more term ends in 2035 · Pro | |||||
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.